OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
21 nov 2011 - 21:40
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus wins drug manufacturing contract from existing client
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), announces today that it has received a commitment from an existing client for OctoPlus to manufacture additional drug product for this client. The contract value will make a material contribution to OctoPlus’ annual revenues in 2012. Further financial details are not disclosed.
Datum laatste update: 01 september 2024